Abstract: A method for the production of clavulanic acid by the fermentation of a clavulanic acid producing microorganism at a controlled level of at least 50 mg/l ammonia has been provided for. Under the application of these reaction conditions surprisingly high production levels of clavulanic acid have been obtained.

Abstract: A process for the manufacture of (all-rac)-?-tocopherol by the acid-catalyzed reaction of trimethylhydroquinone with isophytol or phytol is characterized by carrying out the reaction in the presence of methane trisulphonate as the catalyst in an organic solvent. The product of the process is the most active and industrially most important member of the vitamin E group.

Abstract: Isolated polynucleotides encoding polypeptides having the activity of enzymes in the mevalonate pathway are provided. These sequences are useful for recombinantly producing isoprenoid compounds, such as carotenoids, in particular zeaxanthin. Expression vectors, cultured cells, and methods of making isoprenoid compounds are also provided.

Abstract: Process for cross-linking a polymer or a resin with the help of a peroxide, in the presence of a co-agent, the co-agent used being a compound according to formula 1, in which n is higher than or equal to 2, R1 is an aliphatic or aromatic group and the R2 and R3 groups, independently of each other, can be a hydrogen atom, an aliphatic or an aromatic group. The polymer used preferably is EPDM or CSM.

Abstract: Catalyst for the asymmetric (transfer) hydrogenation represented by the formula MLaXbSc, where M is a transition metal, to be chosen from rhodium and ruthenium, and X is a counter ion and S is a ligand, a ranges from 0.5 to 3 and b and c, each independently, range from 0 to 2, and L is a chiral ligand having the formula (1), where Cn together with the two 2 O-atoms and the P-atom forms a substituted or non-substituted ring with 2-4 C-atoms, R1 and R2 each independently represent H, an optionally substituted alkyl, aryl, alkaryl or aralkyl group or may form a (heterocyclic) ring together with the N-atom to which they are bound. And a process for the asymmetric (transfer) hydrogenation of an olefinically unsaturated compound, ketone, imine or oxime derivate in the presence of a hydrogen donor and of a catalyst, use being made of a catalyst represented by formula MLaXbSc, where M is a transition metal, to be chosen from rhodium, iridium and ruthenium, X is a counter ion, S is a ligand, a ranges from 0.

Abstract: The invention relates to a process for making a multi-filament polyethylene yarn via a gel-spinning process, wherein a spin finish is applied at least once in an amount of 0,1-10 mass % based on the filament, to a filament that contains less than 50 mass % of solvent; the spin finish comprising at least 95 mass % of at least one volatile compound having a boiling point at 0,1 MPa pressure of from 30 to 250° C.; and the spin finish is subsequently removed by exposing the filament to a temperature of below the melting temperature of the filament. With this process a yarn is made that has a very low amount of residues on the surface of the fibres, without the need for a washing or extraction step, showing good mechanical properties, and very suited for e.g. biomedical applications. The invention further relates to a process for converting polyolefin fibres into a semi-finished or end-use product.

Abstract: The invention relates to a soft and flexible surgical soft tissue mesh comprising polyethylene yarns, wherein the polyethylene yarns have a tensile strength of more than 1.0 Gpa and consist of a polyethylene with a relative viscosity of more than 5 dl/g. A further aspect of the invention is a method of producing a soft and flexible surgical soft tissue mesh comprising polyethylene yarns, wherein yarns are applied that comprise filaments made by: a) spinning at least one filament from a solution of polyethylene with a relative viscosity of more than 5 dl/g in a solvent; b) cooling the filament obtained to form a gel filament; c) removing at least partly the solvent from the gel filament; and d) drawing the filament in at least one drawing step before, during or after removing solvent.

Abstract: The present invention relates to a flame retardant polyamide compound comprising a polyamide polymer having a weight-average molecular weight of at least 10.000 g/mol, a polyamide oligomer having a weight-average molecular weight of at most 7500 and a halogen-free phosphorous containing flame retardant. The invention also relates to a process for preparing said flame retardant polyamide compound and to the use of said compound.

Abstract: A purified vitamin B6-phosphate phosphatase (VB6PP), having the following physico-chemical properties: a) Molecular weight: 29,000±5,000 (consisting of a monomer having a molecular weight of 29,000±5,000); b) Co-factor: Mn2+, Mg2+, Co2+, Sn2+, or Ni2+; c) Substrate specificity: active on pyridoxol 5?-phosphate, pyridoxal 5?-phosphate and pyridoxamine 5?-phosphate; d) Optimum temperature: 30–400° C. at pH 7.5; and e) Optimum pH: 7.0–8.0 is disclosed. Also disclosed are a process for producing VB6PP from a microorganism belonging to the genus Sinorhizobium capable of producing VB6PP, a process for producing vitamin B6 from vitamin B6-phosphate (VB6P) utilizing VB6PP, and a cell-free extract of a microorganism belonging to the genus Sinorhizobium capable of producing VB6PP.

Abstract: The present invention describes novel agglomerates in crystalline form of ?-lactam compounds. Furthermore, a process for the preparation of said agglomerates, wherein a solution or suspension of at least one ?-lactam compound in a solvent is mixed with one or more anti-solvents has been described.

Abstract: The invention relates to a curable liquid resin composition which exhibits excellent curability, can be applied at high speed, and produces a cured product having a Young's modulus appropriate for the upjacket layer and excellent coating removal properties of the upjacket layer. The curable liquid resin composition according to the invention comprises: (A) a urethane (meth)acrylate, (B) a reactive diluent, (C) a polymerization initiator, and (D) particles with a number average particle size of 0.1-100 ?m.

Abstract: The invention relates to compositions in the form of a powder or granules containing L-ascorbic acid and/or a pharmaceutically acceptable salt thereof, and pectin in a quantity within the range of about 0.1 to about 10% by weight.

Abstract: The present invention relates to radiation curable coating compositions, to coatings formed by curing these compositions, to processes for preparing such coatings, to articles comprising such coatings, and to antireflective coating systems. An aspect of the invention concerns the application of such coatings to hardcoats or display systems.

Abstract: The present invention relates to 1,3-benzoxazole or benzodiazole UV-A sunscreens and to compositions, in particular topical compositions, containing the above UV-A sunscreens.

Abstract: To provide a photocurable liquid resin composition that can produce cured products exhibiting a high refractive index, good shape restorability, and superior adhesion to substrates. The photocurable resin composition comprises (A) 20-80 wt % of a urethane (meth) acrylate obtained by reacting a polyether polyol having an alkyleneoxy structure in the molecule, an organic polyisocyanate compound, and a (meth) acrylate containing a hydroxyl group, (B) 10-70 wt % of a monofunctional ethylenically unsaturated compound, (C) 5-25 wt % of a (meth) acrylate monomer having four or more functional groups, and (D) 0.1-10 wt % of a photoinitiator. Cured products are useful for forming an optical part such as a lens of a lens sheet or a back light using the lens sheet.

Abstract: A photocurable resin composition suitable for use in three-dimensional photofabrication comprising (A) a cationically polymerizable organic compound, (B) a cationic photoinitiator, and (C) a (co)polymer obtainable by (co)polymerization of monomers comprising at least one (meth)acrylate-group comprising monomer. A process for producing a three-dimensional object which comprises the use of a washing agent having a Hansen-solubility between 27-35 (Mpa)1/2.

Abstract: Artificial intervertebral disc, comprising a nucleus of flexible material with the shape of a flattened body, with a lower and an upper side connected by a lateral surface, having a rounded-preferably circular or ellipsoid-shape, around which at least substantially radially oriented windings of a traction-resistant fibre have been applied. The fibres have a tensile strength of at least 1 GPa and a modulus of at least 10 GPa.

Abstract: The invention relates to a process for the preparation of a 2,4-dideoxyhexose or a 2,4,6-trideoxyhexose from a substituted or unsubstituted carbonyl compound with at least 2 carbon atoms and at least one ?-hydrogen atom and a substituted or unsubstituted aldehyde in the presence of an aldolase and water, the reaction between the substituted or unsubstituted carbonyl compound with at least 2 carbon atoms and at least one ?-hydrogen atom and the substituted or unsubstituted aldehyde being carried out at a carbonyl concentration of at most 6 moles/l of reaction mixture and the final concentration of the 2,4-dideoxyhexose or the 2,4,6-trideoxyhexose being at least 2 mass % of the reaction mixture. The invention also relates to the use of a 2,4-dideoxyhexose or a 2,4,6-trideoxyhexose obtained by means of a process according to the invention in the preparation of a medicine, particularly in the preparation of a statine.

Abstract: The present invention provides the use of Enzyme B of G. oxydans DSM 4025, as disclosed in EP 0 832 974 A2, in a process for producing L-ascorbic acid from L-gulose, L-galactose, L-idose or L-talose, or from L-gulono-1,4-lactone (and its acid form, L-gulonic acid) and from L-galactono-1,4-lactone (and its acid form, L-galactonic acid).

Abstract: Acid-stable proteases of the subtilisin family, their use in animal feed, feed-additives and feed compositions containing such proteases, and methods for the treatment of vegetable proteins using such proteases.